Arkadios Wealth Advisors Invitae Corp Transaction History

Arkadios Wealth Advisors

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 03, 2022	SELL	$14.7 - $28.67 $3,483 - $6,794	-237 Closed	0 $0
Q3 2021 Oct 19, 2021	SELL	$24.31 - $33.6 $19,448 - $26,880	-800 Reduced 77.15%	237 $6,000
Q2 2021 Jul 28, 2021	BUY	$26.09 - $40.4 $23,794 - $36,844	912 Added 729.6%	1,037 $34,000
Q1 2021 Apr 26, 2021	SELL	$33.06 - $56.93 $4,463 - $7,685	-135 Reduced 51.92%	125 $4,000
Q4 2020 Feb 09, 2021	BUY	$39.09 - $57.4 $10,163 - $14,924	260 New	260 $10,000
Q2 2020 Aug 10, 2020	SELL	$11.71 - $30.29 $2,482 - $6,421	-212 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$7.64 - $27.5 $1,619 - $5,830	212 New	212 $2.9 Million

2.12M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Arkadios Wealth Advisors, based on Form 13F filings with the SEC.

Stay updated on Arkadios Wealth Advisors with notifications on news.